[go: up one dir, main page]

KR930016100A - 약제학적 조성물 - Google Patents

약제학적 조성물 Download PDF

Info

Publication number
KR930016100A
KR930016100A KR1019930000673A KR930000673A KR930016100A KR 930016100 A KR930016100 A KR 930016100A KR 1019930000673 A KR1019930000673 A KR 1019930000673A KR 930000673 A KR930000673 A KR 930000673A KR 930016100 A KR930016100 A KR 930016100A
Authority
KR
South Korea
Prior art keywords
composition
pharmaceutically acceptable
treating
pharmaceutical composition
tumors
Prior art date
Application number
KR1019930000673A
Other languages
English (en)
Other versions
KR100274101B1 (ko
Inventor
볼라그 베르너
프란시스 그립포 조우지프
레빈 아써
Original Assignee
프리돌린 클라우스너, 롤란트 보러
에프. 호프만-라 로슈 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25239599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR930016100(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 프리돌린 클라우스너, 롤란트 보러, 에프. 호프만-라 로슈 에이지 filed Critical 프리돌린 클라우스너, 롤란트 보러
Publication of KR930016100A publication Critical patent/KR930016100A/ko
Application granted granted Critical
Publication of KR100274101B1 publication Critical patent/KR100274101B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

9-시스 레틴산, 이의 염 및 에스테르는 악성 종양 및 전악성종양성 상피 병변, 피부 광손상, 피지 분비 증가에 의해 유발된 질환, 및 건선의 치료에 사용될 수 있다.

Description

약제학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 9-시스 레틴산, 약제학적으로 허용되는 이의 염 또는 약제학적으로 허용되는 이의 가수분해성 에스테르 및 치료적 불활성의 약제학적으로 허용되는 담체를 함유하는 약제학적 조성물.
  2. 제1항에 있어서, 전악성종양 또는 암전구성 상피 병변 또는 상피 종양을 치료하기 위한 조성물.
  3. 제1항에 있어서, 광손상된 피부와 관련된 상태를 치료하기 위한 조성물.
  4. 제1항에 있어서, 피지 분비를 감소시키기 위한 조성물.
  5. 제1항에 있어서, 건선을 치료하기 위한 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930000673A 1992-01-22 1993-01-20 9-시스 레틴산을 함유하는 약제학적 조성물 KR100274101B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82374192A 1992-01-22 1992-01-22
CH07/823,7410 1992-01-22
US7/823,741 1992-01-22

Publications (2)

Publication Number Publication Date
KR930016100A true KR930016100A (ko) 1993-08-26
KR100274101B1 KR100274101B1 (ko) 2000-12-15

Family

ID=25239599

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930000673A KR100274101B1 (ko) 1992-01-22 1993-01-20 9-시스 레틴산을 함유하는 약제학적 조성물

Country Status (2)

Country Link
US (1) US5428071A (ko)
KR (1) KR100274101B1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506917B1 (en) * 1991-12-18 2003-01-14 The Salk Institute For Biological Studies Compounds and compositions useful for modulation of processes mediated by RXR
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5968989A (en) * 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
US6495406B1 (en) * 2000-08-31 2002-12-17 Micron Technology, Inc. Method of forming lightly doped drain MOS transistor including forming spacers on gate electrode pattern before exposing gate insulator
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
CA2509955A1 (en) * 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
DE10305138A1 (de) * 2003-02-07 2004-08-26 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
EP1527774A1 (en) * 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
US20120070518A1 (en) * 2004-01-12 2012-03-22 Natrogen Therapeutics International, Inc. Methods and compositions for treating psoriasis
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute

Also Published As

Publication number Publication date
US5428071A (en) 1995-06-27
KR100274101B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
NO930206L (no) Farmasoeytiske blandinger
RU93005355A (ru) Фармакологические композиции
KR930016100A (ko) 약제학적 조성물
Plewig et al. Anti-inflammatory effects of 13-cis-retinoic acid: an in vivo study
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DE3850109D1 (de) 13-trans-retinsäureester.
SE8804036L (sv) Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma
IT7827167A0 (it) Procedimento e apparecchiatura perl'ottenimento di acqua di elevata purezza priva di germi e di particelle, per preparati medicinali per iniezioni e per scopi tecnici.
EP0297733A3 (en) Pharmaceutical compositions comprising catecholic butanes
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
FI863976A0 (fi) Terapeutisk komposition.
SE8303732D0 (sv) Compositon for reducing sebum secretion
IE830664L (en) Treating acne
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
IE780534L (en) Pharmaceutical composition
KR970069969A (ko) 신규한 레티노이드
ATE120090T1 (de) Behandlung gealterter haut mit oraler 13-cis- retinsäure.
WO1993015713A2 (en) Method and compositions for treating acne
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
FR2081478A1 (en) Treatment of acne and psoriasis with vitamin - a acids
GB1472086A (en) Pharmaceutical composition for treatment of liver diseases
IT1257884B (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930120

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980119

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930120

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19991215

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20000615

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20000907

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20000908

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

Patent event code: PG17011E01I

Patent event date: 20010202

Comment text: Request for Publication of Correction

Publication date: 20010302

PR1001 Payment of annual fee

Payment date: 20030825

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20040823

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20050824

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20060824

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20070823

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20080825

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20090824

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20100825

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20100825

Start annual number: 11

End annual number: 11

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20120809